Multicentre validation of 4-well azole agar plates as a screening method for detection of clinically relevant azole-resistant Aspergillus fumigatus
Open Access
- 4 October 2017
- journal article
- research article
- Published by Oxford University Press (OUP) in Journal of Antimicrobial Chemotherapy
- Vol. 72 (12) , 3325-3333
Abstract
Azole-resistant Aspergillus fumigatus is emerging worldwide. Reference susceptibility testing methods are technically demanding and no validated commercial susceptibility tests for moulds currently exist. In this multicentre study a 4-well azole-containing screening agar method was evaluated using clinically relevant isolates. Forty WT and 39 cyp51A mutant A. fumigatus [G54 (n = 10), M220 (n = 10), TR34/L98H (n = 9) and TR46/Y121F/T289A (n = 10)] were tested individually and as simulated mixed samples (sampling 4 WT and 1 mutant colonies). EUCAST MICs were determined following E.Def 9.3. In-house and commercial 4-well plates containing agars supplemented with 4 mg/L itraconazole, 1 mg/L voriconazole, 0.5 mg/L posaconazole and no antifungal, respectively, were evaluated. Growth was scored (0–3) by two independent observers in three laboratories. Inter-plate, inter-observer, essential and categorical agreement, sensitivity and specificity were calculated. CYP51A genotype and antifungal compound-specific MICs and growth patterns were documented. The inter-observer agreement was excellent with 86%–99% identical scores (range 80%–100%) for both plates. The qualitative agreement (no growth versus growth) was excellent (median 95%–100%, range 87%–100%, overall). The overall sensitivity and specificity for the 4-well plate (no growth versus growth) was 99% (range 97%–100%) and 99% (95%–100%), respectively. The sensitivity for simulated WT/mutant specimens was 94% (range 83%–100%) for the WT-TR34/L98H combination, but 100% for the WT/G54W combination. The performance remained unchanged using only itraconazole- and voriconazole-containing agars, but was lower for the other combinations. Implementation of the 4-well screening plate in routine laboratories will allow easy and reliable detection of the most common azole-resistant A. fumigatus.Keywords
This publication has 44 references indexed in Scilit:
- Azole Resistance inAspergillus fumigatus: Can We Retain the Clinical Use of Mold-Active Antifungal Azoles?Clinical Infectious Diseases, 2015
- First Detection of TR 46 /Y121F/T289A and TR 34 /L98H Alterations in Aspergillus fumigatus Isolates from Azole-Naive Patients in Denmark despite Negative Findings in the EnvironmentAntimicrobial Agents and Chemotherapy, 2014
- Azole-resistant Aspergillus fumigatus in the environment of northern Italy, May 2011 to June 2012Eurosurveillance, 2014
- Discovery of a hapE Mutation That Causes Azole Resistance in Aspergillus fumigatus through Whole Genome Sequencing and Sexual CrossingPLOS ONE, 2012
- Azole-Resistant Invasive Aspergillosis: Relationship to AgricultureCurrent Fungal Infection Reports, 2012
- Environmental Study of Azole-Resistant Aspergillus fumigatus and Other Aspergilli in Austria, Denmark, and SpainAntimicrobial Agents and Chemotherapy, 2010
- Azole antifungal resistance in Aspergillus fumigatus: 2008 and 2009Journal of Antimicrobial Chemotherapy, 2010
- Azole resistance in Aspergillus fumigatus: a side-effect of environmental fungicide use?The Lancet Infectious Diseases, 2009
- Frequency and Evolution of Azole Resistance in Aspergillus fumigatus Associated with Treatment Failure1Emerging Infectious Diseases, 2009
- Aspergillosis—and a misleading sensitivity resultThe Lancet, 2007